This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 1764
Title
Increased pro-inflammatory mediators leads to Activation, Stellate cells
Upstream event
Downstream event
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Protein Alkylation leading to Liver Fibrosis | adjacent | High | Brendan Ferreri-Hanberry (send email) | Open for citation & comment | WPHA/WNT Endorsed |
Taxonomic Applicability
Sex Applicability
| Sex | Evidence |
|---|---|
| Unspecific | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| All life stages | High |
HSC Initiation is associated with rapid gene induction resulting from paracrine stimulation by inflammatory cells and injured hepatocytes . Also Kupffer cell infiltration and activation play a prominent role in HSC activation.[Li et al., 2008]
Lymphocytes, especially CD4 T-helper (Th) lymphocytes, help orchestrate the host response via cytokine production and can differentiate into Th1 and Th2 subsets. In general, Th1 cells produce cytokines promoting cell-mediated immunity, including interferon (IFN)-γ, TNF, and interleukin (IL)-2. Th2 cells produce IL-4, IL-5, IL-6, and IL-13 and promote humoral immunity. Results from previous experimental models imply that Th2 lymphocytes favor fibrogenesis in liver injury over Th1 lymphocytes. [Shi et al., 1997] However, recent studies of Wynn [Wynn,2004] suggest that more than two T-cell subsets underlying a highly complex, orchestrated response are involved, and they also provide us a more important paradigm for how these intersecting pathways may regulate fibrosis. In animal models, IL-13 has emerged as a key mediator because it increases TGF-β1 and MMP expression by macrophages, whereas IL-4 has a limited role. One study examined the activity of IL-13 in cultured HSCs and suggested that IL-4 and IL-13 directly affect HSCs by increasing collagen production and suppressing HSC proliferation. [Sugimoto et al., 2005]
Leukocytes recruited to the liver during injury join with Kupffer cells in producing compounds that modulate HSC behavior
Transforming growth factor beta 1 (TGF-β1) is the most potent fibrogenic factor for hepatic stellate cells (HSCs). In response to TGF-β1, HSCs activate into myofibroblast-like cells, producing type I, III and IV collagen, proteoglycans like biglycan and decorin, glycoproteins like laminin, fibronectin, tenascin and glycosaminoglycan. [Kisseleva and Brenner, 2007] In the further course of events activated HSCs themselves express TGF-β1. TGF-β1 induces its own mRNA to sustain high levels in local sites of liver injury. The effects of TGF-β1 are mediated by intracellular signalling via Smad proteins. Smads 2 and 3 are stimulatory whereas Smad 7 is inhibitory. Smad1/5/8, MAP kinase and PI3 kinase are further signalling pathways in different cell types for TGF-β1 effects. [Parsons et al., 2007] Concomitant with increased TGF-β production, HSC increase production of collagen. Connective tissue growth factor (CTGF) is a profibrogenic peptide induced by TGF-β, that stimulates the synthesis of collagen type I and fibronectin and may mediate some of the downstream effects of TGF-β. It is upregulated during activation of HSC, suggesting that its expression is another determinant of a fibrogenic response to TGF-β. [Williams et al.,2000] During fibrogenesis, tissue and blood levels of active TGF-β are elevated and overexpression of TGF-β1 in transgenic mice can induce fibrosis. Additionally, experimental fibrosis can be inhibited by anti-TGF-β treatments with neutralizing antibodies or soluble TbRs (TGF-β receptors). [Qi et al., 1999]
| ID | Experimental Design | Species | Upstream Observation | Downstream Observation | Citation (first author, year) | Notes |
|---|
| Title | First Author | Biological Plausibility |
Dose Concordance |
Temporal Concordance |
Incidence Concordance |
|---|
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Human [Kolios et al., 2006; Guo and Friedman, 2007]
Rat [Dooley et al., 2000]